Highbridge Capital Management LLC Acorda Therapeutics Inc Transaction History

Highbridge Capital Management LLC

  • $333 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$1.61 - $2.5 $454,330 - $705,482
-282,193 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$2.3 - $4.71 $649,043 - $1.33 Million
282,193 New
282,193 $674,000

Others Institutions Holding ACOR

# of Institutions
1
Shares Held
133K
Call Options Held
0
Put Options Held
0
View Full List

About ACORDA THERAPEUTICS INC

ACOR Quotes by TradingView
  • Ticker ACOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 24,338,400
  • Market Cap $6.33M
  • Description
  • Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...
More about ACOR
Track This Portfolio

Track Highbridge Capital Management LLC Portfolio

Follow Highbridge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highbridge Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email